Correspondence to Editorial on the USF1/HKDC1/SMS Axis in Lenvatinib Resistant and Immune Escape in HCC.

Chen S, Dai Z

DOI: 10.3350/cmh.2026.0487
Published: 2026 Nov 5
Container: Clinical and molecular hepatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3350/cmh.2026.0487,
  title = {Correspondence to Editorial on the USF1/HKDC1/SMS Axis in Lenvatinib Resistant and Immune Escape in HCC.},
  author = {Chen S and Dai Z},
  year = {2026},
  journal = {Clinical and molecular hepatology},
  doi = {10.3350/cmh.2026.0487},
  url = {https://doi.org/10.3350/cmh.2026.0487}
}

RIS

TY  - JOUR
TI  - Correspondence to Editorial on the USF1/HKDC1/SMS Axis in Lenvatinib Resistant and Immune Escape in HCC.
AU  - Chen S
AU  - Dai Z
PY  - 2026
JO  - Clinical and molecular hepatology
DO  - 10.3350/cmh.2026.0487
UR  - https://doi.org/10.3350/cmh.2026.0487
ER  -

APA

S, C., & Z, D. (2026). Correspondence to Editorial on the USF1/HKDC1/SMS Axis in Lenvatinib Resistant and Immune Escape in HCC.. Clinical and molecular hepatology. https://doi.org/10.3350/cmh.2026.0487

Source records

pubmed · retrieved 2026-11-10T08:44:45.852Z